Literature DB >> 35008218

Differential Spatial Distribution of TSPO or Amino Acid PET Signal and MRI Contrast Enhancement in Gliomas.

Lena Kaiser1, Adrien Holzgreve1, Stefanie Quach2, Michael Ingrisch3, Marcus Unterrainer1,3, Franziska J Dekorsy1, Simon Lindner1, Viktoria Ruf4, Julia Brosch-Lenz1, Astrid Delker1, Guido Böning1, Bogdana Suchorska5, Maximilian Niyazi6,7, Christian H Wetzel8, Markus J Riemenschneider9, Sophia Stöcklein3, Matthias Brendel1, Rainer Rupprecht8, Niklas Thon2, Louisa von Baumgarten2, Jörg-Christian Tonn2,7, Peter Bartenstein1,7, Sibylle Ziegler1, Nathalie L Albert1,7.   

Abstract

In this study, dual PET and contrast enhanced MRI were combined to investigate their correlation per voxel in patients at initial diagnosis with suspected glioblastoma. Correlation with contrast enhancement (CE) as an indicator of BBB leakage was further used to evaluate whether PET signal is likely caused by BBB disruption alone, or rather attributable to specific binding after BBB passage. PET images with [18F]GE180 and the amino acid [18F]FET were acquired and normalized to healthy background (tumor-to-background ratio, TBR). Contrast enhanced images were normalized voxel by voxel with the pre-contrast T1-weighted MRI to generate relative CE values (rCE). Voxel-wise analysis revealed a high PET signal even within the sub-volumes without detectable CE. No to moderate correlation of rCE with TBR voxel-values and a small overlap as well as a larger distance of the hotspots delineated in rCE and TBR-PET images were detected. In contrast, voxel-wise correlation between both PET modalities was strong for most patients and hotspots showed a moderate overlap and distance. The high PET signal in tumor sub-volumes without CE observed in voxel-wise analysis as well as the discordant hotspots emphasize the specificity of the PET signals and the relevance of combined differential information from dual PET and MRI images.

Entities:  

Keywords:  FET PET; TSPO PET; amino acid PET; contrast enhancement; glioma; spatial correlation

Year:  2021        PMID: 35008218      PMCID: PMC8750092          DOI: 10.3390/cancers14010053

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  51 in total

Review 1.  Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

Authors:  Nathalie L Albert; Michael Weller; Bogdana Suchorska; Norbert Galldiks; Riccardo Soffietti; Michelle M Kim; Christian la Fougère; Whitney Pope; Ian Law; Javier Arbizu; Marc C Chamberlain; Michael Vogelbaum; Ben M Ellingson; Joerg C Tonn
Journal:  Neuro Oncol       Date:  2016-04-21       Impact factor: 12.300

2.  The validity of 18F-GE180 as a TSPO imaging agent.

Authors:  Paolo Zanotti-Fregonara; Mattia Veronese; Belen Pascual; Robert C Rostomily; Federico Turkheimer; Joseph C Masdeu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-17       Impact factor: 9.236

Review 3.  Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer.

Authors:  Michael Ingrisch; Steven Sourbron
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-04-06       Impact factor: 2.745

4.  The development of an automated and GMP compliant FASTlab™ Synthesis of [(18) F]GE-180; a radiotracer for imaging translocator protein (TSPO).

Authors:  Torild Wickstrøm; Alan Clarke; Ingvil Gausemel; Eric Horn; Karina Jørgensen; Imtiaz Khan; Dimitrios Mantzilas; Thanushan Rajanayagam; Dirk-Jan in 't Veld; William Trigg
Journal:  J Labelled Comp Radiopharm       Date:  2013-09-23       Impact factor: 1.921

5.  TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis.

Authors:  Marcus Unterrainer; C Mahler; L Vomacka; S Lindner; J Havla; M Brendel; G Böning; B Ertl-Wagner; T Kümpfel; V M Milenkovic; R Rupprecht; M Kerschensteiner; P Bartenstein; Nathalie L Albert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-09       Impact factor: 9.236

6.  Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter.

Authors:  Sujata Sridharan; Joel Raffel; Ashwini Nandoskar; Chris Record; David J Brooks; David Owen; David Sharp; Paolo A Muraro; Roger Gunn; Richard Nicholas
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

7.  TSPO-PET and diffusion-weighted MRI for imaging a mouse model of infiltrative human glioma.

Authors:  Hayet Pigeon; Elodie A Pérès; Charles Truillet; Benoit Jego; Fawzi Boumezbeur; Fabien Caillé; Bastian Zinnhardt; Andreas H Jacobs; Denis Le Bihan; Alexandra Winkeler
Journal:  Neuro Oncol       Date:  2019-06-10       Impact factor: 12.300

8.  TSPO PET imaging of natalizumab-associated progressive multifocal leukoencephalopathy.

Authors:  Christoph Mahler; Adrian-Minh Schumacher; Marcus Unterrainer; Lena Kaiser; Thomas Höllbacher; Simon Lindner; Joachim Havla; Birgit Ertl-Wagner; Maximilian Patzig; Klaus Seelos; Julia Neitzel; Matthias Mäurer; Markus Krumbholz; Imke Metz; Wolfgang Brück; Christine Stadelmann; Doron Merkler; Achim Gass; Vladimir Milenkovic; Peter Bartenstein; Nathalie L Albert; Tania Kümpfel; Martin Kerschensteiner
Journal:  Brain       Date:  2021-10-22       Impact factor: 13.501

9.  TSPO imaging using the novel PET ligand [18F]GE-180: quantification approaches in patients with multiple sclerosis.

Authors:  Lena Vomacka; Nathalie Lisa Albert; Simon Lindner; Marcus Unterrainer; Christoph Mahler; Matthias Brendel; Larissa Ermoschkin; Astrid Gosewisch; Anika Brunegraf; Christopher Buckley; Tania Kümpfel; Rainer Rupprecht; Sibylle Ziegler; Martin Kerschensteiner; Peter Bartenstein; Guido Böning
Journal:  EJNMMI Res       Date:  2017-10-26       Impact factor: 3.138

10.  Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain.

Authors:  Claire Feeney; Gregory Scott; Joel Raffel; S Roberts; Christopher Coello; Amy Jolly; Graham Searle; A P Goldstone; David J Brooks; Richard S Nicholas; William Trigg; Roger N Gunn; David J Sharp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-28       Impact factor: 9.236

View more
  3 in total

Review 1.  In Vivo Quantitative Imaging of Glioma Heterogeneity Employing Positron Emission Tomography.

Authors:  Cristina Barca; Claudia Foray; Bastian Zinnhardt; Alexandra Winkeler; Ulrich Herrlinger; Oliver M Grauer; Andreas H Jacobs
Journal:  Cancers (Basel)       Date:  2022-06-27       Impact factor: 6.575

2.  Reduced Acquisition Time [18F]GE-180 PET Scanning Protocol Replaces Gold-Standard Dynamic Acquisition in a Mouse Ischemic Stroke Model.

Authors:  Artem Zatcepin; Steffanie Heindl; Ulrike Schillinger; Lena Kaiser; Simon Lindner; Peter Bartenstein; Anna Kopczak; Arthur Liesz; Matthias Brendel; Sibylle I Ziegler
Journal:  Front Med (Lausanne)       Date:  2022-02-10

3.  Longitudinal [18F]GE-180 PET Imaging Facilitates In Vivo Monitoring of TSPO Expression in the GL261 Glioblastoma Mouse Model.

Authors:  Adrien Holzgreve; Dennis Pötter; Matthias Brendel; Michael Orth; Lorraine Weidner; Lukas Gold; Maximilian A Kirchner; Laura M Bartos; Lena M Unterrainer; Marcus Unterrainer; Katja Steiger; Louisa von Baumgarten; Maximilian Niyazi; Claus Belka; Peter Bartenstein; Markus J Riemenschneider; Kirsten Lauber; Nathalie L Albert
Journal:  Biomedicines       Date:  2022-03-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.